Q2 2023

Source filing unavailable

Q2 2023 · —

Revenue

$82.58K

no prior Q2 2022 on file

Net Income

-$219.89K

no prior Q2 2022 on file

EPS Diluted

-$0.00

no prior Q2 2022 on file

Gross Profit$75,491—

Operating Income-$183,608—

Margins · derived

Gross margin

Same quarter

Metric	Q2 2023	Q2 2012	Q2 2011
Revenue	$82.58K	$15.52M	$25.93M
Net Income	-$219.89K	$1.81M	$4.88M
EPS Diluted	-$0.00	$0.13	$0.38

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Cannabis Bioscience International Holdings, Inc. · CIK 1411057 · Engraved from SEC EDGAR